FDA 483 - Palisades Compounding Pharmacy - March 15, 2023

Palisades Compounding Pharmacy in Pacific Palisades, CA, a producer of non-sterile drugs, was cited for significant deficiencies during an FDA inspection. Observations included inadequate segregation and cleaning practices for hazardous drug production, leading to potential cross-contamination. Additionally, the firm was found to have used expired excipients in the production of finished drug products, compromising their quality.